UroLase: Laser Trans-Urethral Ablation for Bladder Tumors

What is UroLase: Laser Trans-Urethral Ablation for Bladder Tumors?

UroLase laser trans-urethral ablation system by INVAMED for bladder tumor treatment. Cutting-edge laser technology for precise and effective tumor ablation. CE marked oncology laser.

How does UroLase: Laser Trans-Urethral Ablation for Bladder Tumors work?

先进激光系统，用于精准外科干预，以最小的组织损伤实现治疗效果，恢复快速。

What are the key features of UroLase: Laser Trans-Urethral Ablation for Bladder Tumors?

• 靶向消融：在病变界面产生强烈能量，汽化或切除肿瘤组织，减少对邻近结构的热损伤。
• 精确的光束控制：可以精细控制消融深度，特别有利于精细的膀胱解剖结构。
• 内窥镜指导：UroLase 可以通过标准刚性或柔性膀胱镜引入，确保肿瘤边缘的直接可视化。
• 门诊潜力：许多浅表膀胱肿瘤病例可以在侵入性较小的门诊设施中进行治疗，从而缩短住院时间。
• 符合人体工程学的激光控制台：通常与已知的内窥镜或成像设备集成，简化操作员的工作流程。
• 多功能纤维尖端：可定制长度或尖端类型，以适应不同的病变位置，例如膀胱三角、侧壁。

Who manufactures UroLase: Laser Trans-Urethral Ablation for Bladder Tumors?

UroLase: Laser Trans-Urethral Ablation for Bladder Tumors is manufactured by INVAMED, a globally recognized medical device company headquartered in Ankara, Turkey. INVAMED holds over 100 international patents and exports CE marked devices to more than 80 countries. The company is ISO 13485 certified and FDA registered through Standard Technology Solutions, Inc. at One World Trade Center, New York.

What category does UroLase: Laser Trans-Urethral Ablation for Bladder Tumors belong to?

UroLase: Laser Trans-Urethral Ablation for Bladder Tumors is part of the Oncology Ablation product portfolio by INVAMED. This category includes advanced medical devices designed for interventional procedures performed by healthcare professionals worldwide.

Which medical specialties use UroLase: Laser Trans-Urethral Ablation for Bladder Tumors?

UroLase: Laser Trans-Urethral Ablation for Bladder Tumors is used by specialists in Oncological Surgery, Urology. These physicians rely on INVAMED devices for minimally invasive diagnostic and therapeutic procedures.

Is UroLase: Laser Trans-Urethral Ablation for Bladder Tumors CE marked and FDA registered?

Yes. UroLase: Laser Trans-Urethral Ablation for Bladder Tumors carries CE marking under EU MDR 2017/745 and is manufactured in ISO 13485 certified facilities. It is available in the U.S. market through FDA-registered Standard Technology Solutions, Inc.